GG 260 (Hydroxychloroquine 200 mg)
Pill imprint GG 260 has been identified as Hydroxychloroquine sulfate 200 mg.
Hydroxychloroquine is used in the treatment of systemic lupus erythematosus; rheumatoid arthritis; malaria prevention; undifferentiated connective tissue disease; lyme disease, arthritis (and more), and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy. Hydroxychloroquine 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GG 260 (Hydroxychloroquine 200 mg)
- 200 mg
- 9.00 mm
- Prescription only
- Drug Class:
- Antimalarial quinolines
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- N - Not a controlled drug
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- dibasic calcium phosphate
Hydroxychloroquine sulfate is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...